You can now read 5 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

Pfizer to relocate Alewife workers to Kendall Square

Drug giant Pfizer Inc. said it is planning to relocate the majority of its 530 employees at research facilities in Cambridge’s Alewife neighborhood to Kendall Square sometime next year, joining roughly 400 Pfizer employees who are already working in Kendall Square, a hotbed of the life sciences industry.

Pfizer said it plans to hire a broker to explore either selling or subleasing four buildings in Cambridge, including three on Cambridge Park Drive in Alewife.

Continue reading below

Pfizer said one reason for the move is that it is looking to make the most efficient use of its global real estate. ­Another reason: Pfizer wants to create a single, integrated research-and-development community that can easily ­access and collaborate with biomedical researchers and other partners.

In Kendall Square, meanwhile, a building at 610 Main St. is under construction. Pfizer expects that building to be ready for occupancy early next year. Most employees from Alewife will move there. Other Alewife employees will relocate to an existing Pfizer space at 700 Main St., though others could be transferred to a complex in Andover, Pfizer said.

“We expect that there will be minimal impact to the size of Pfizer’s workforce in the state of Massachusetts, given that most colleagues will be moving to other Pfizer sites or leased space in Massachusetts,” a Pfizer spokeswoman said in an e-mail.

Chris Reidy can be reached at
Loading comments...
Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
Please enter a valid email will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of